{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:59:39Z","timestamp":1782943179624,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006393","name":"Universidad de Granada","doi-asserted-by":"publisher","award":["102023"],"award-info":[{"award-number":["102023"]}],"id":[{"id":"10.13039\/501100006393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.idnow.2026.105244","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T15:12:20Z","timestamp":1767539540000},"page":"105244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of pneumococcal serotypes, vaccination uptake, and prognosis of invasive pneumococcal disease: A 9-year multicentre cohort study in Granada (Andalusia, Spain)"],"prefix":"10.1016","volume":"56","author":[{"given":"Elvira","family":"Mar\u00edn-Caba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Enrique","family":"Reinoso-Camino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Chueca-Porcuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Valero-Ubierna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Francisca","family":"Enr\u00edquez-Maroto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-6037","authenticated-orcid":false,"given":"Mario","family":"Rivera-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-6145","authenticated-orcid":false,"given":"Jos\u00e9 Juan","family":"Jim\u00e9nez-Mole\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2026.105244_b0005","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1080\/21645515.2021.1923348","article-title":"Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis","volume":"17","author":"Navarro-Torn\u00e9","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.idnow.2026.105244_b0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","article-title":"Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review","volume":"137","author":"Torres","year":"2018","journal-title":"Repir Med"},{"key":"10.1016\/j.idnow.2026.105244_b0015","unstructured":"European Centers for Disease Control and Prevention (ECDC) [Internet]. 2025. Invasive pneumococcal disease \u2013 Annual Epidemiological Report for 2022 [cited March 12, 2025]. Available at: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-pneumococcal-disease-annual-epidemiological-report-2022."},{"key":"10.1016\/j.idnow.2026.105244_b0020","unstructured":"Soler Soneira M, Sastre-Garc\u00eda M, Amillategui-Dos-Santos R, L\u00f3pez-Per\u00e9a N, Masa-Calles J, Cano Portero R. Enfermedad neumoc\u00f3cica invasiva en Espa\u00f1a. Periodo 2015-2021 [cited March 12, 2025]. Available at: https:\/\/revista.isciii.es\/index.php\/bes\/article\/view\/1284."},{"key":"10.1016\/j.idnow.2026.105244_b0025","unstructured":"UK Government [Internet]. 2025. HM Treasury. Green book, Chapter 25. Pneumococcal [cited March 12, 2025]. Available at: https:\/\/assets.publishing.service.gov.uk\/media\/684b1fbc1c8d5c94e201abae\/Green_Book__Chapter_25_pneumococcal_12_6_25.pdf."},{"issue":"2","key":"10.1016\/j.idnow.2026.105244_b0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4321\/s2173-92772024000200003","article-title":"Enfermedad Neumoc\u00f3cica Invasiva en Espa\u00f1a en 2023","volume":"32","author":"Soler-Soneira","year":"2024","journal-title":"Bolet\u00edn Epidemiol\u00f3gico Semanal"},{"key":"10.1016\/j.idnow.2026.105244_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines7010013","article-title":"The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects","volume":"7","author":"Papadatou","year":"2019","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.idnow.2026.105244_b0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.eimc.2015.09.002","article-title":"Vacunas antineumoc\u00f3cicas. Nuevas vacunas conjugadas para el adulto [Pneumococcal vaccines. New conjugate vaccines for adults]","volume":"33","author":"Campins","year":"2015","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.idnow.2026.105244_b0045","unstructured":"Spanish Ministry of Health [Internet]. n.d. Health Promotion and prevention. Vaccines and vaccination programmes. Invasive Pneumococcal Disease [updated July 2025; cited April 24, 2025]. Available at: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/vacunas\/ciudadanos\/enfNeumococicaInvasiva.htm."},{"key":"10.1016\/j.idnow.2026.105244_b0050","unstructured":"Andavac [Internet]. 2024. Immunization Plan in Andalusia. Andalusian Health Government (Spain). Vaccination in risk groups. Pneumococcus [cited March 12, 2025]. Available at: https:\/\/www.andavac.es\/vacunacion-en-grupos-de-riesgo\/neumococo\/."},{"key":"10.1016\/j.idnow.2026.105244_b0055","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/microorganisms11061376","article-title":"Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review","volume":"11","author":"Teixeira","year":"2023","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.idnow.2026.105244_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One."},{"issue":"8","key":"10.1016\/j.idnow.2026.105244_b0065","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idnow.2026.105244_b0070","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1093\/infdis\/jiae351","article-title":"Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities","volume":"231","author":"El Safadi","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idnow.2026.105244_b0075","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1080\/21645515.2020.1763739","article-title":"Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups","volume":"16","author":"Boey","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.idnow.2026.105244_b0080","unstructured":"Danis K, Varon E, Lepoutre A, Janssen C, Forestier E, Epaulard O, et al. Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France. Open Forum Infect Dis. 2019;6(12):ofz510."},{"key":"10.1016\/j.idnow.2026.105244_b0085","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.idnow.2026.105244_b0090","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3201\/eid2808.212469","article-title":"Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta","volume":"28","author":"Versluys","year":"2022","journal-title":"Canada. Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idnow.2026.105244_b0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12879-020-05140-1","article-title":"Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study","volume":"20","author":"Chan","year":"2020","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.idnow.2026.105244_b0100","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3390\/jcm14051612","article-title":"Predominant Pneumococcal Serotypes in Isolates Causing Invasive Disease in a Spanish Region: An Examination of Their Association with Clinical Factors, Antimicrobial Resistance, and Vaccination Coverage","volume":"14","author":"Diab-Casares","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.idnow.2026.105244_b0105","unstructured":"Andalusian Health Government [Internet]. 2025. Immunization Plan in Andalusia. Vaccination in risk groups. Influenza and Covid-19 vaccination campaign [cited April 10, 2025]. Available at: Instruccion_Vacunacion_Gripe_Covid19_Andalucia_cambios_resaltados.pdf."},{"key":"10.1016\/j.idnow.2026.105244_b0110","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2469424","article-title":"Global distribution and characteristics of pneumococcal serotypes in adults","volume":"21","author":"Maeda","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.idnow.2026.105244_b0115","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.vaccine.2024.01.004","article-title":"A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults\u226560 years of age in Japan, South Korea, and Taiwan","volume":"42","author":"Haranaka","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.idnow.2026.105244_b0120","article-title":"Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study","volume":"41","author":"Calvo-Silveria","year":"2024","journal-title":"Lancet Reg Health Eur."},{"key":"10.1016\/j.idnow.2026.105244_b0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cmi.2019.10.034","article-title":"Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain","volume":"26","author":"Gonz\u00e1lez-D\u00edaz","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2026.105244_b0130","unstructured":"Sociedad Espa\u00f1ola de Medicina Preventiva, Salud P\u00fablica y Gesti\u00f3n Sanitaria (SEMPSPGS) [Internet]. 2022. [Consensus about vaccination against pneumococcus in the adult]. Spanish. [cited April 10, 2025]. Available at: https:\/\/sempspgs.es\/wp-content\/uploads\/2025\/05\/Consenso-de-la-SEMPSPGS-sobre-vacunacion-frente-a-NEUMOCOCO-en-el-adulto.pdf."},{"key":"10.1016\/j.idnow.2026.105244_b0135","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1038\/s41598-021-91234-y","article-title":"Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.idnow.2026.105244_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235107","article-title":"Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study","volume":"15","author":"Rivera-Izquierdo","year":"2020","journal-title":"PloS one."},{"key":"10.1016\/j.idnow.2026.105244_b0145","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2023.2168354","article-title":"Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis","volume":"10","author":"Sikj\u00e6r","year":"2023","journal-title":"Eur Clin Respir J."},{"key":"10.1016\/j.idnow.2026.105244_b0150","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Vacunolog\u00eda [Internet]. 2021. Vacunas [cited April 10, 2025]. Available at: https:\/\/vacunas.org\/wp-content\/uploads\/2024\/02\/Vacunas_2021_compressed.pdf."}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:29:03Z","timestamp":1782941343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991926000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666991926000011"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105244","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of pneumococcal serotypes, vaccination uptake, and prognosis of invasive pneumococcal disease: A 9-year multicentre cohort study in Granada (Andalusia, Spain)","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105244"}}